ID Biomedical Shares Up on Vaccine Contract
84876
Shares of ID Biomedical jumped after the company reported Monday that it signed long-term agreements with the three largest flu vaccine wholesalers in the United States in light of the shortage of vaccine for the current flu season.
446395
The US government on Tuesday awarded Sanofi-Aventis (SASY.PA: Quote, Profile, Research) a contract worth up to $41 million through 2008 to ensure that enough eggs are available for future flu vaccine production.
665690
The developing biopharmaceutical company announces a share offering.
581751
THE REGION Idera Pharmaceuticals Inc. of Cambridge signed a drug-development deal with Merck &amp; Co. in which the New Jersey drug giant will pay $20 million cash and buy $10 million in stock for the rights to use Idera's immune-boosting technology in potential Merck vaccines. If the vaccines succeed, the deal could be worth up to $425 million in additional ...
328806
Shares of Protein Design Labs Inc (PDLI.O: Quote, Profile, Research) rose on Thursday after Swiss drugmaker Roche Holding AG (ROG.
520141
Shares in biotechnology company Gilead Sciences Inc  could climb another 20 percent to 25 percent on strong demand for its existing AIDS and flu drugs as well as from new products in the pipeline, Barron's reported in its July 9 issue.
72952
VANCOUVER - The Canadian government has ordered 145,000 extra doses of flu vaccine from ID Biomedical, expected to be delivered sometime next week.
307769
AmerisourceBergen Corp.  said on Monday it has signed a 10-year agreement with ID Biomedical Corp.  of Canada to distribute ID Biomedical's flu vaccine in the United States.
712896
Introgen Therapeutics Inc. reported Friday that it raised an additional $7.8 million from the same European institutional investors with whom it placed shares Wednesday.
54609
SEC upgrades investigation into vaccine manufacturer.
351155
Shares of Nastech Pharmaceutical Co. Inc. jumped as much as 43 percent on Monday after it said it formed an alliance with Merck & Co. to develop its appetite-regulating treatment for obesity.
634232
Bowing to pressure from an Icos Corp.   shareholder, Eli Lilly and Co.  said on Monday  it has increased its offer for the biotechnology company to  $2.3 billion from an earlier bid of $2.1 billion.
730755
AmerisourceBergen Corp. ABC.N said  on Monday it has signed a 10-year agreement with ID Biomedical  Corp. IDB.TO of Canada to distribute ID Biomedical's flu  vaccine in the United States.
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
126877
MONTREAL (CP) - ID Biomedical, Canada's main supplier of flu vaccine, has elected to sell its remaining surplus doses of vaccine in Canada, not the United States, the company announced Tuesday.
156795
Eli Lilly and Co.  said on Monday it has increased its offer for biotechnology company Icos Corp.  to $2.3 billion from $2.1 billion after at least one Icos shareholder called the earlier bid too low.
334497
ID Biomedical Corp.   signed a 10-year U.S. distribution deal for its Fluviral drug that could reap sales of &#36;2.3 billion and help U.S. authorities fill a flu vaccine shortage, the company said on Monday.